Ignite Creation Date:
2024-05-06 @ 1:49 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04130152
Status:
COMPLETED
Last Update Posted:
2022-10-25
First Post:
2019-10-14
Brief Title:
Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
SOLTI Breast Cancer Research Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-14
First Submit QC Date:
October 15 2019
Study First Post Date:
2019-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-10-25
Last Update Post Date Type:
ACTUAL